2 results
Approved WMOCompleted
The aim of this study is to investigate what proportion of HBeAg negative, inactive carriers of the hepatitis B virus with low (< 20,000 IU/mL) load will lose HBsAg when treated with nucleot(s)ide analogue/Peg-IFN combination therapy.
Approved WMOCompleted
Primary Objective: to investigate if INPW will reduce wound complications such as wound dehiscence, wound infection (SSI), seroma leak and wound necrosis after arterial vascular surgery.Secondary Objective(s): to investigate if INPWT will prevent…